Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/animal-model-of-axonal-guillain-barr-syndrome-induced-by-sensitization-sgB4UqE90v
References (31)
-
T. Takigawa, H. Yasuda, R. Kikkawa, Y. Shigeta, T. Saida, H. Kitasato (1995)
Antibodies against GM1 ganglioside affect K+ and NA+ currents in isolated rat myelinated nerve fibersAnnals of Neurology, 37
-
Thomas (1991)
Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of RanvierActa Neuropathol, 82
-
T. Crawford, Sung-Tsang Hsieh, Brenda Schryer, J. Glass (1995)
Prolonged axonal survival in transected nerves of C57BL/Ola mice is independent of ageJournal of Neurocytology, 24
-
N. Hirota, Ryuji Kaji, Hugh Bostock, Katsuro Shindo, T. Kawasaki, K. Mizutani, Nobuyuki Oka, Nobuo Kohara, Takahiko Saida, Jun Kimura (1997)
The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons.Brain : a journal of neurology, 120 ( Pt 12)
-
Konstantinos Paparounas, G. O’Hanlon, C. O'Leary, E. Rowan, H. Willison (1999)
Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro.Brain : a journal of neurology, 122 ( Pt 5)
-
Kasama Kasama, Hisano Hisano, Nakajima Nakajima (1996)
Microscale analysis of glycosphingolipids by TLC blotting/secondary ion mass spectrometry: a novel blood group A‐active glycosphingolipid and changes in glycosphingolipid expression in rat mammary tumour cells with different metastatic potentialsGlycoconj J, 13
-
M. Odaka, N. Yuki, E. Nobile‐Orazio, M. Carpo, K. Hirata (2000)
Antibodies to GM1(NeuGc) in Guillain–Barré syndrome after ganglioside therapyJournal of the Neurological Sciences, 175
-
G. Aspinall, Armando McDonald, H. Pang, L. Kurjanczyk, John Penner (1994)
Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome.Biochemistry, 33 1
-
Mrcp Hadden, MD Cornblath, Fro Hughes, MD Zielasek, MD Hartung, MD Toyka, PhD Swan, D. Hadden (1998)
Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcomeAnnals of Neurology, 44
-
MD Griffin, MD Li, MD Ho, MD’ Tian, MD Gao, M. Xue, MD Mishu, MD Cornblath, MD’ Macko, MD McKhann, Mds Asbury, JW Griffin, Ho, W. Tian, Xutt CY, Macko Ghl, Asbury Parhology, Dr Neurolog (1996)
Pathology of the motor‐sensory axonal Guillain‐Barré syndromeAnnals of Neurology, 39
-
T. Ho, Sung-Tsang Hsieh, I. Nachamkin, H. Willison, K. Sheikh, J. Kiehlbauch, K. Flanigan, J. McArthur, D. Cornblath, G. Mckhann, J. Griffin (1997)
Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after campylobacter infectionNeurology, 48
-
T. Feasby, J. Gilbert, W. Brown, C. Bolton, A. Hahn, W. Koopman, D. Zochodne (1986)
An acute axonal form of Guillain-Barré polyneuropathy.Brain : a journal of neurology, 109 ( Pt 6)
-
T. Ho, H. Willison, I. Nachamkin, C. Li, J. Veitch, H. Ung, G. Wang, R. Liu, D. Cornblath, A. Asbury, J. Griffin, G. Mckhann, G. Mckhann (1999)
Anti‐GD1a antibody is associated with axonal but not demyelinating forms of Guillain‐Barré syndromeAnnals of Neurology, 45
-
N. Yuki, T. Taki, F. Inagaki, T. Kasama, M. Takahashi, K. Saito, S. Handa, T. Miyatake (1993)
A bacterium lipopolysaccharide that elicits Guillain-Barre syndrome has a GM1 ganglioside-like structureThe Journal of Experimental Medicine, 178
-
R. D'alessandro, M. Casmiro, M. Guarino, Emilia-Romagna Members (1999)
Risk factors for Guillain-Barré syndrome: a population-based case-control studyJournal of Neurology, 246
-
T. Saida, K. Saida, S. Dorfman, D. Silberberg, A. Sumner, M. Manning, R. Lisak, Mark Brown (1979)
Experimental allergic neuritis induced by sensitization with galactocerebroside.Science, 204 4397
-
G. Mckhann, G. Mckhann, D. Cornblath, J. Griffin, T. Ho, T. Ho, C. Li, Z. Jiang, Hu-sheng Wu, G. Zhaori, Y. Liu, L. Jou, T. Liu, C. Gao, J. Mao, M. Blaser, B. Mishu, A. Asbury (1993)
Acute motor axonal neuropathy: A frequent cause of acute flaccid paralysis in ChinaAnnals of Neurology, 33
-
J. Griffin, C. Li, T. Ho, P. Xue, C. Macko, C. Gao, C. Yang, M. Tian, B. Mishu, D. Cornblath, G. Mckhann, G. Mckhann, A. Asbury (1995)
Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases.Brain : a journal of neurology, 118 ( Pt 3)
-
C. Hafer-Macko, S. Hsieh, T. Ho, K. Sheikh, D. Cornblath, Chun Li, G. Mckhann, A. Asbury, J. Griffin (1996)
Acute motor axonal neuropathy: An antibody‐mediated attack on axolemmaAnnals of Neurology, 40
-
I. Illa, N. Ortiz, Eduard Gallard, C. Juárez, Josep Grau, M. Dalakas (1995)
Acute axonal Guillain‐Barré syndrome with IgG antibodies against motor axons following parenteral gangliosidesAnnals of Neurology, 38
-
Zhukovskiĭ IuG (1968)
The effect of temperature on kinetics of the hydrolytic activity of the acid phosphatase of the prostate glandBiochemistry, 33
-
N. Yuki, Y. Tagawa, F. Irie, Y. Hirabayashi, S. Handa (1997)
Close association of Guillain–Barré syndrome with antibodies to minor monosialogangliosides GM1b and GM1αJournal of Neuroimmunology, 74
-
S. Kusunoki, J. Shimizu, Atsuro Chiba, Y. Ugawa, S. Hitoshi, I. Kanazawa (1996)
Experimental sensory neuropathy induced by sensitization with ganglioside GD1bAnnals of Neurology, 39
-
M. Santoro, A. Uncini, M. Corbo, S. Staugaitis, F. Thomas, A. Hays, N. Latov (1992)
Experimental conduction block induced by serum from a patient with anti‐GM1 antibodiesAnnals of Neurology, 31
-
W. Bradley (1990)
Critical review of gangliosides and thyrotropin‐releasing hormone in peripheral neuromuscular diseasesMuscle & Nerve, 13
-
Y. Nagai, T. Momoi, Masaki Saito, E. Mitsuzawa, S. Ohtani (1976)
Ganglioside syndrome, a new autoimmune neurologic disorder, experimentally induced with brain gangliosidesNeuroscience Letters, 2
-
V. Govoni, E. Granieri, M. Tola, E. Paolino, I. Casetta, E. Fainardi, V. Monetti (1997)
Exogenous gangliosides and Guillain-Barré syndrome. An observational study in the local health district of Ferrara, Italy.Brain : a journal of neurology, 120 ( Pt 7)
-
H. Yoshino, T. Ariga, N. Latov, T. Miyatake, Y. Kushi, T. Kasama, S. Handa, R. Yu (1993)
Fucosyl‐GM1 in Human Sensory Nervous Tissue Is a Target Antigen in Patients with Autoimmune NeuropathiesJournal of Neurochemistry, 61
-
K. Sheikh, T. Deerinck, Mark Ellisman, J. Griffin (1999)
The distribution of ganglioside-like moieties in peripheral nerves.Brain : a journal of neurology, 122 ( Pt 3)
-
S. Kuwabara, N. Yuki, M. Koga, T. Hattori, D. Matsuura, M. Miyake, M. Noda (1998)
IgG Anti‐GM1 antibody is associated with reversible conduction failure and axonal degeneration in guillain‐barré syndromeAnnals of Neurology, 44
-
G. Landi, R. D'alessandro, B. Dossi, S. Ricci, I. Simone, A. Ciccone (1993)
Guillain-Barré syndrome after exogenous gangliosides in Italy.British Medical Journal, 307
- Publisher
- Wiley
- Copyright
- Copyright © 2001 Wiley‐Liss, Inc.
- ISSN
- 0364-5134
- eISSN
- 1531-8249
- DOI
- 10.1002/ana.1012
- Publisher site
- See Article on Publisher Site
Abstract
Some humans develop the axonal form of Guillain‐Barré syndrome after receiving bovine brain ganglioside. On sensitization with the ganglioside mixture, all of a group of rabbits injected developed high anti‐GM1 IgG antibody titers, flaccid limb weakness of acute onset, and a monophasic illness course. Pathological findings for the peripheral nerves showed predominant Wallerian‐like degeneration, with neither lymphocytic infiltration nor demyelination. IgG was deposited on the axons of the anterior roots, and GM1 was proved to be present on the axons of peripheral nerves. Sensitization with purified GM1 also induced axonal neuropathy, indicating that GM1 was the immunogen in the mixture. A model of human axonal Guillain‐Barré syndrome has been established that uses inoculation with a bovine brain ganglioside mixture or isolated GM1. This model may help to clarify the molecular pathogenesis of the syndrome and to develop new treatments for it.
Journal
Annals of Neurology – Wiley
Published: Jun 1, 2001